Guj. Terce Lab
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
March 22 (Reuters) - Gujarat Terce Laboratories Ltd GUTL.BO:
TO CONSIDER PROPOSAL FOR RAISING OF FUNDS
Source text for Eikon: ID:nBSE5D77P5
Further company coverage: GUTL.BO
(([email protected];))
March 22 (Reuters) - Gujarat Terce Laboratories Ltd GUTL.BO:
TO CONSIDER PROPOSAL FOR RAISING OF FUNDS
Source text for Eikon: ID:nBSE5D77P5
Further company coverage: GUTL.BO
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Guj. Terce Lab do?
Gujarat Terce Laboratories Limited, founded in 1985 in India, is a pharmaceutical company based in Gandhinagar, Gujarat.
Who are the competitors of Guj. Terce Lab?
Guj. Terce Lab major competitors are Unick Fix-A-Form, Medicamen Organics, Parmax Pharma, JFL Life Sciences, Medistep Healthcare, Rekvina Labs, Walpar Nutritions. Market Cap of Guj. Terce Lab is ₹27 Crs. While the median market cap of its peers are ₹26 Crs.
Is Guj. Terce Lab financially stable compared to its competitors?
Guj. Terce Lab seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Guj. Terce Lab pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Guj. Terce Lab latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Guj. Terce Lab allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments
How strong is Guj. Terce Lab balance sheet?
Balance sheet of Guj. Terce Lab is strong. But short term working capital might become an issue for this company.
Is the profitablity of Guj. Terce Lab improving?
The profit is oscillating. The profit of Guj. Terce Lab is ₹2.22 Crs for TTM, -₹0.98 Crs for Mar 2025 and ₹0.24 Crs for Mar 2024.
Is the debt of Guj. Terce Lab increasing or decreasing?
The net debt of Guj. Terce Lab is decreasing. Latest net debt of Guj. Terce Lab is -₹1.56 Crs as of Mar-26. This is less than Mar-25 when it was -₹0.55 Crs.
Is Guj. Terce Lab stock expensive?
Guj. Terce Lab is not expensive. Latest PE of Guj. Terce Lab is 12.05, while 3 year average PE is 21.14. Also latest EV/EBITDA of Guj. Terce Lab is 6.79 while 3yr average is 52.32.
Has the share price of Guj. Terce Lab grown faster than its competition?
Guj. Terce Lab has given lower returns compared to its competitors. Guj. Terce Lab has grown at ~-38.08% over the last 1yrs while peers have grown at a median rate of -32.0%
Is the promoter bullish about Guj. Terce Lab?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Guj. Terce Lab is 40.03% and last quarter promoter holding is 40.03%.
Are mutual funds buying/selling Guj. Terce Lab?
There is Insufficient data to gauge this.